| __timestamp | Eli Lilly and Company | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 2242216 |
| Thursday, January 1, 2015 | 4796400000 | 4536244 |
| Friday, January 1, 2016 | 5243900000 | 5184803 |
| Sunday, January 1, 2017 | 5281800000 | 3068742 |
| Monday, January 1, 2018 | 5051200000 | 7178000 |
| Tuesday, January 1, 2019 | 5595000000 | 16267000 |
| Wednesday, January 1, 2020 | 6085700000 | 23191000 |
| Friday, January 1, 2021 | 7025900000 | 21453000 |
| Saturday, January 1, 2022 | 7190800000 | 15265000 |
| Sunday, January 1, 2023 | 9313400000 | 25189000 |
Unleashing insights
In the competitive world of pharmaceuticals, innovation is key. Eli Lilly and Company, a stalwart in the industry, has consistently outpaced Soleno Therapeutics, Inc. in research and development (R&D) spending over the past decade. From 2014 to 2023, Eli Lilly's R&D expenses surged by nearly 97%, reaching a peak of approximately $9.3 billion in 2023. In contrast, Soleno Therapeutics, a smaller player, saw its R&D investment grow by over 1,000% during the same period, yet it remains a fraction of Eli Lilly's budget.
This stark difference highlights the scale and resources of these companies. While Eli Lilly's substantial investment underscores its commitment to maintaining a competitive edge, Soleno's growth in R&D spending reflects its ambition to innovate and expand its footprint. As the pharmaceutical landscape evolves, these investments will be crucial in shaping the future of healthcare.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Alnylam Pharmaceuticals, Inc.
Comparing Innovation Spending: Eli Lilly and Company and Biogen Inc.
Eli Lilly and Company vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Research and Development Investment: Eli Lilly and Company vs Catalyst Pharmaceuticals, Inc.
R&D Insights: How Eli Lilly and Company and Protagonist Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Eli Lilly and Company and Galapagos NV
Research and Development Investment: Johnson & Johnson vs Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Soleno Therapeutics, Inc.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: argenx SE vs Soleno Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Soleno Therapeutics, Inc.
Research and Development Investment: TG Therapeutics, Inc. vs Soleno Therapeutics, Inc.